VolitionRx Limited Amortization of Leased Asset
VolitionRx Limited (VNRX) reported Amortization of Leased Asset of $97.31 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfLeasedAsset · last filed 2017-11-09
- VolitionRx Limited amortization of leased asset for the quarter ending 2017-09-30 was $37.72K, a 21.61% increase year-over-year.
- VolitionRx Limited amortization of leased asset for the quarter ending 2017-06-30 was $30.26K, a 1.32% increase year-over-year.
- VolitionRx Limited amortization of leased asset for the quarter ending 2017-03-31 was $29.32K, a 6.18% decline year-over-year.
- VolitionRx Limited amortization of leased asset for the quarter ending 2016-09-30 was $31.02K, a 0.17% decline year-over-year.
| Period end | Amortization of Leased Asset 3 month | Amortization of Leased Asset 6 month | Amortization of Leased Asset 9 month |
|---|---|---|---|
| 2017-09-30 | $37.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $67.98K derived: sum of 2 quarters · filed 2017-11-09 | $97.31K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $30.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $59.59K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $29.32K 10-Q · filed 2017-05-11 | ||
| 2016-09-30 | $31.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $60.89K derived: sum of 2 quarters · filed 2017-11-09 | $92.14K 10-Q · filed 2017-11-09 |
| 2016-06-30 | $29.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $61.12K 10-Q · filed 2017-08-10 | |
| 2016-03-31 | $31.25K 10-Q · filed 2017-05-11 | ||
| 2015-09-30 | $31.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $41.26K 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $10.19K 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |